We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

69 hedge funds and large institutions have $330M invested in Jasper Therapeutics in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $3.25M | Put options by funds: $1.03M

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

13% more funds holding

Funds holding: 61 → 69 (+8)

10.01% more ownership

Funds ownership: 86.51% → 96.52% (+10%)

13% less capital invested

Capital invested by funds: $380M → $330M (-$50.4M)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
69
Holders Change
+8
Holders Change %
+13.11%
% of All Funds
1%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
26
Increased
17
Reduced
11
Closed
18
Calls
$3.25M
Puts
$1.03M
Net Calls
+$2.22M
Net Calls Change
-$1.19M

Top Buyers

Rank Fund Capital Flow
1
PCH
Polar Capital Holdings
United Kingdom
+$13.9M
2
BlackRock
BlackRock
New York
+$12M
3
Deutsche Bank
Deutsche Bank
Germany
+$4.66M
4
State Street
State Street
Massachusetts
+$3.63M
5
Morgan Stanley
Morgan Stanley
New York
+$3.19M

Top Sellers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
-$5.12M
2
Millennium Management
Millennium Management
New York
-$2.12M
3
ABG
Ally Bridge Group
New York
-$1.71M
4
Jane Street
Jane Street
New York
-$1.23M
5
SFM
Sphera Funds Management
Israel
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$3.21M +$1.48M +61,676 +77%
SCM
27
Silverarc Capital Management
Massachusetts
$2.49M – – –
IC
28
Ikarian Capital
Texas
$2.39M – – –
CF
29
Cantor Fitzgerald
New York
$1.4M +$638K +26,603 +76%
Walleye Capital
30
Walleye Capital
New York
$1.2M +$1.26M +52,669 New
FIM
31
Fernwood Investment Management
Massachusetts
$1.12M – – –
Mariner
32
Mariner
Kansas
$1.07M -$132K -5,498 -10%
LP
33
LMR Partners
United Kingdom
$904K -$98.8K -4,117 -9%
Goldman Sachs
34
Goldman Sachs
New York
$822K +$868K +36,201 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$740K +$781K +32,579 New
Charles Schwab
36
Charles Schwab
California
$736K +$777K +32,407 New
LPC
37
Lion Point Capital
New York
$726K – – –
Northern Trust
38
Northern Trust
Illinois
$665K +$158K +6,602 +29%
BFM
39
Boothbay Fund Management
New York
$529K – – –
Millennium Management
40
Millennium Management
New York
$522K -$2.12M -88,376 -79%
EI
41
EAM Investors
California
$489K – – –
N
42
Nuveen
North Carolina
$469K +$496K +20,681 New
BAMCO Inc
43
BAMCO Inc
New York
$454K +$480K +20,000 New
Invesco
44
Invesco
Georgia
$434K +$459K +19,121 New
SC
45
Shay Capital
New York
$371K +$392K +16,357 New
American Century Companies
46
American Century Companies
Missouri
$322K +$72.7K +3,032 +27%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$300K +$317K +13,231 New
AGM
48
Alpine Global Management
New York
$243K +$257K +10,719 New
LSA
49
Leonteq Securities AG
Switzerland
$182K – – –
CF
50
Corebridge Financial
Texas
$138K +$146K +6,090 New
1
2
3 4

JSPR Hedge Fund Activity: Q2 2024 in Review

69 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q2 2024, worth a combined $330M — down 13% from $380M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new JSPR positions and 18 closed out — a net gain of 8 holders — while 17 added to existing stakes and 11 trimmed.

The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $13.9M. The largest seller was Octagon Capital Advisors, cutting an estimated $5.12M.

  • 69 institutional investors held Jasper Therapeutics (JSPR) as of Q2 2024, up from 61 in Q1 2024.
  • Funds reported $330M of Jasper Therapeutics stock for Q2 2024, down 13% quarter-over-quarter.
  • 26 funds opened new Jasper Therapeutics positions in Q2 2024 and 18 closed out, a net change of +8 holders.
  • The largest Jasper Therapeutics buyer in Q2 2024 was Polar Capital Holdings, an estimated $13.9M added.
  • The largest Jasper Therapeutics seller in Q2 2024 was Octagon Capital Advisors, an estimated $5.12M sold.

Based on aggregated 13F filings for Q2 2024.